Background: Evidence shows that the use of protease inhibitors (PIs) in HIV/AIDS patients leads to the development of diabetes mellitus. Some degree of insulin resistance has also been noted in HIV infected patients not on protease inhibitor therapy and this may cause glucose intolerance and overt diabetes mellitus.Objective: To describe the epidemiological and laboratory characteristics associated with diabetes mellitus in HIV positive patients who are HAART naive.Design: Cross-sectional, cohort analysis of patients with HIV infection on HIV care programme.Setting: Kisumu District Hospital and Mater Hospital.Subjects: Ten adult patients with HIV infection at initial presentation to the clinic.Main Outcome Measures: Blood Sugar, CD4+ Cell C...
OBJECTIVE - The aims of this study were to determine the incidence of diabetes among HIV-infected pa...
BACKGROUND: Human immunodeficiency virus (HIV)-infected persons may be at increased risk for develop...
Introduction: HIV-positive patients receiving combination antiretroviral therapy (cART) frequently e...
Background: Zimbabwe has a double burden of diseases, with HIV epidemic and increased prevalence of ...
HIV infection, as well as its treatment with highly active retroviral therapy (HAART), is associated...
BACKGROUND: Fasting hyperglycemia has been associated with HIV protease inhibitor (PI) therapy. OBJE...
International audienceOBJECTIVE: To evaluate the incidence and determinants of diabetes in a cohort ...
Background: The hallmark of HIV infection is the progressive loss of immune cells called the CD4 cel...
Background. There is little in the literature on HIV and diabetes mellitus (DM) in sub-Saharan Afric...
Item does not contain fulltextBACKGROUND: As HIV management has become more successful during the pa...
International audienceBackground: Diabetes mellitus (DM) is a major and increasing public health pro...
Background. Abnormal glucose metabolism in HIV-infected patients has largely been attributed to the ...
Type 2 diabetes (T2D) has a reported greater prevalence and poorer treatment outcomes in people livi...
Background: The risk of diabetes mellitus (DM) in human immunodeficiency virus (HIV)–infected patien...
OBJECTIVE - The aims of this study were to determine the incidence of diabetes among HIV-infected pa...
OBJECTIVE - The aims of this study were to determine the incidence of diabetes among HIV-infected pa...
BACKGROUND: Human immunodeficiency virus (HIV)-infected persons may be at increased risk for develop...
Introduction: HIV-positive patients receiving combination antiretroviral therapy (cART) frequently e...
Background: Zimbabwe has a double burden of diseases, with HIV epidemic and increased prevalence of ...
HIV infection, as well as its treatment with highly active retroviral therapy (HAART), is associated...
BACKGROUND: Fasting hyperglycemia has been associated with HIV protease inhibitor (PI) therapy. OBJE...
International audienceOBJECTIVE: To evaluate the incidence and determinants of diabetes in a cohort ...
Background: The hallmark of HIV infection is the progressive loss of immune cells called the CD4 cel...
Background. There is little in the literature on HIV and diabetes mellitus (DM) in sub-Saharan Afric...
Item does not contain fulltextBACKGROUND: As HIV management has become more successful during the pa...
International audienceBackground: Diabetes mellitus (DM) is a major and increasing public health pro...
Background. Abnormal glucose metabolism in HIV-infected patients has largely been attributed to the ...
Type 2 diabetes (T2D) has a reported greater prevalence and poorer treatment outcomes in people livi...
Background: The risk of diabetes mellitus (DM) in human immunodeficiency virus (HIV)–infected patien...
OBJECTIVE - The aims of this study were to determine the incidence of diabetes among HIV-infected pa...
OBJECTIVE - The aims of this study were to determine the incidence of diabetes among HIV-infected pa...
BACKGROUND: Human immunodeficiency virus (HIV)-infected persons may be at increased risk for develop...
Introduction: HIV-positive patients receiving combination antiretroviral therapy (cART) frequently e...